Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Teva
US Department of Justice
Deloitte
UBS
Dow
Julphar
Fuji
Merck

Generated: December 10, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ESCITALOPRAM OXALATE

« Back to Dashboard

Clinical Trials for Escitalopram Oxalate

Trial ID Title Status Sponsor Phase Summary
NCT00149825 Combining Antidepressant Medication and Psychotherapy for Insomnia to Improve Depression Outcome Completed National Institute of Mental Health (NIMH) Phase 2 This study will examine the effectiveness of a combination of antidepressant medication and sleep-focused psychotherapy to simultaneously treat sleep difficulties and depression.
NCT00149825 Combining Antidepressant Medication and Psychotherapy for Insomnia to Improve Depression Outcome Completed Stanford University Phase 2 This study will examine the effectiveness of a combination of antidepressant medication and sleep-focused psychotherapy to simultaneously treat sleep difficulties and depression.
NCT00222820 Depression: The Search for Treatment-Relevant Phenotypes-Pilot Study Completed Mental Health Intervention Research Center (MHIRC) Phase 4 We are doing this pilot study to learn more about four aspects of treating depression: 1. The features of a depressed person’s mood and anxiety and how these features affect a person’s capacity to get better and stay better. 2. If depressed people with certain features of mood and anxiety respond better to therapy, medication or a combination of therapy and medication. 3. Whether or not a person’s personality traits affect how they respond to treatment. 4. The gene involved in processing antidepressant medication
NCT00222820 Depression: The Search for Treatment-Relevant Phenotypes-Pilot Study Completed University of Pittsburgh Phase 4 We are doing this pilot study to learn more about four aspects of treating depression: 1. The features of a depressed person’s mood and anxiety and how these features affect a person’s capacity to get better and stay better. 2. If depressed people with certain features of mood and anxiety respond better to therapy, medication or a combination of therapy and medication. 3. Whether or not a person’s personality traits affect how they respond to treatment. 4. The gene involved in processing antidepressant medication
NCT00235508 Safety and Efficacy of Eszopiclone in Patients With Generalized Anxiety Disorder Completed Sunovion Phase 4 To determine the safety and efficacy of eszopiclone as adjunctive therapy in the treatment of insomnia in patients with insomnia related to Generalized Anxiety Disorder. All subjects will receive an approved anxiolytic agent and will be randomized to nightly therapy with either eszopiclone or placebo.
NCT00387348 Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer Terminated National Cancer Institute (NCI) Phase 3 RATIONALE: Escitalopram may help improve depression and quality of life in patients with advanced lung or gastrointestinal cancer. It is not yet known whether escitalopram is more effective than a placebo in treating depression in patients with advanced lung or gastrointestinal cancer. PURPOSE: This randomized clinical trial is studying the side effects of escitalopram and to see how well it works compared to a placebo in treating depression in patients with advanced lung or gastrointestinal cancer.
NCT00387348 Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer Terminated Massachusetts General Hospital Phase 3 RATIONALE: Escitalopram may help improve depression and quality of life in patients with advanced lung or gastrointestinal cancer. It is not yet known whether escitalopram is more effective than a placebo in treating depression in patients with advanced lung or gastrointestinal cancer. PURPOSE: This randomized clinical trial is studying the side effects of escitalopram and to see how well it works compared to a placebo in treating depression in patients with advanced lung or gastrointestinal cancer.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Escitalopram Oxalate

Condition Name

Condition Name for Escitalopram Oxalate
Intervention Trials
Depression 6
Healthy 4
Spinal Cord Injury 2
Insomnia 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Escitalopram Oxalate
Intervention Trials
Depression 9
Depressive Disorder 6
Depressive Disorder, Major 3
Disease 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Escitalopram Oxalate

Trials by Country

Trials by Country for Escitalopram Oxalate
Location Trials
United States 38
China 19
India 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Escitalopram Oxalate
Location Trials
Illinois 3
California 3
West Virginia 2
North Carolina 2
Massachusetts 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Escitalopram Oxalate

Clinical Trial Phase

Clinical Trial Phase for Escitalopram Oxalate
Clinical Trial Phase Trials
Phase 4 3
Phase 3 2
Phase 2/Phase 3 1
[disabled in preview] 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Escitalopram Oxalate
Clinical Trial Phase Trials
Completed 10
Recruiting 2
Terminated 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Escitalopram Oxalate

Sponsor Name

Sponsor Name for Escitalopram Oxalate
Sponsor Trials
National Cancer Institute (NCI) 2
Torrent Pharmaceuticals Limited 2
Mylan Pharmaceuticals 2
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Escitalopram Oxalate
Sponsor Trials
Other 13
Industry 8
NIH 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Cerilliant
Argus Health
AstraZeneca
UBS
Federal Trade Commission
Chubb
Julphar
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.